All these genetic alterations usually perturb the normal cellular traffic of NPM1 protein in malignant cells, but we will focus here on the biological and clinical significance of NPM1 gene mutations occurring in acute myeloid leukemia (AML) and other myeloid neoplasms [2,3,4,5]. This evidence concerns the gene NPM1 and myeloid neoplasm.